Literature DB >> 11282758

Forced expiratory flow in uninfected infants and children born to HIV-infected mothers.

A A Colin1, J Sunil Rao, X C Chen, J M Hunter, J Hanrahan, P Hiatt, M Kattan, A Koumbourlis, R B Mellins, H H Peavy, A Platzker, A Ting, S Steinbach, M E Wohl.   

Abstract

The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV (P(2)C(2) HIV) Study is a multicenter study examining pulmonary and cardiac outcomes in offspring of HIV-infected mothers. This portion of the P(2)C(2) study tests the hypothesis that infants exposed to, but uninfected by, maternal HIV have normal maximal expiratory flow at functional residual capacity (V'max,(FRC)). We obtained 500 measurements of V'max,(FRC) by rapid thoracic compression in 285 children ages 6-30 mo in five U.S. centers. The data were compared with those from a healthy cohort of children described elsewhere. V'max,(FRC) rose with height in a linear relationship. The slope of the regression line in the exposed infants did not differ statistically from the slope in the comparison group, but the intercept was about 20% lower (p < 0.001). Height and weight were comparable in the two cohorts, and the differences between intercepts persisted after adjusting for birth weight and gestational age. However, maternal HIV infection cannot be assumed to be the cause as the cohorts may have differed in other variables, such as socioeconomic status and frequency of maternal smoking and drug use. Also, measurements varied substantially within and between our five centers, probably in part because of different racial and ethnic distributions. In summary, maternal HIV infection probably has only a modest effect, if any, on maximal expiratory flow at functional residual capacity in uninfected infants.

Entities:  

Mesh:

Year:  2001        PMID: 11282758     DOI: 10.1164/ajrccm.163.4.9901040

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Maximal expiratory flow at FRC (V'maxFRC): Methods of selection and differences in reported values.

Authors:  Anastassios C Koumbourlis; Xin C Chen; J Sunil Rao; Mark D Schluchter; Kirk Easley; Andrew A Colin; Peter Hiatt; Meyer Kattan; Kevin McCarthy; Robert B Mellins; Hannah Peavy; Arnold C G Platzker; Suzanne Steinbach; Andrew Ting; Michael D Weisner; Mary Ellen B Wohl
Journal:  Pediatr Pulmonol       Date:  2004-04

2.  Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.

Authors:  Stephanie D Davis; Margaret Rosenfeld; Gwendolyn S Kerby; Lyndia Brumback; Margaret H Kloster; James D Acton; Andrew A Colin; Carol K Conrad; Meeghan A Hart; Peter W Hiatt; Peter J Mogayzel; Robin C Johnson; Stephanie L Wilcox; Robert G Castile
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

3.  Long-term pulmonary complications in perinatally HIV-infected youth.

Authors:  William T Shearer; Denise L Jacobson; Wendy Yu; George K Siberry; Murli Purswani; Suzanne Siminski; Laurie Butler; Erin Leister; Gwendolyn Scott; Russell B Van Dyke; Ram Yogev; Mary E Paul; Ana Puga; Andrew A Colin; Meyer Kattan
Journal:  J Allergy Clin Immunol       Date:  2017-03-06       Impact factor: 10.793

4.  Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study.

Authors:  Samuel B Foster; Kenneth McIntosh; Bruce Thompson; Ming Lu; Wanrong Yin; Kenneth C Rich; Hermann Mendez; Leslie K Serchuck; Clemente Diaz; Mary E Paul; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2008-06-10       Impact factor: 10.793

Review 5.  Lung function in HIV-infected children and adolescents.

Authors:  Leah N Githinji; Diane M Gray; Heather J Zar
Journal:  Pneumonia (Nathan)       Date:  2018-06-25

6.  Respiratory Function in Healthy Taiwanese Infants: Tidal Breathing Analysis, Passive Mechanics, and Tidal Forced Expiration.

Authors:  Shen-Hao Lai; Sui-Ling Liao; Tsung-Chieh Yao; Ming-Han Tsai; Man-Chin Hua; Kuo-Wei Yeh; Jing-Long Huang
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.